PDL has spoken with many pharmacists impacted by the changes to S3 supply requirements for salbutamol inhalers made by TGA earlier this year. These changes created difficulties for pharmacists and clients when a diagnosis of a respiratory condition or prior history of supply from the pharmacist could not be confirmed.
PDL is pleased to advise its pharmacist members that representations made to the TGA by the profession’s peak bodies, with input and support from PDL, has led to the change announced on 1 October 2020.
New entry for the supply of salbutamol as a S3 medic…
